Preclinical examination of clofarabine in pediatric ependymoma: intratumoral concentrations insufficient to warrant further study

Cancer Chemotherapy and Pharmacology
Y T PatelClinton F Stewart

Abstract

Clofarabine, a deoxyadenosine analog, was an active anticancer drug in our in vitro high-throughput screening against mouse ependymoma neurospheres. To characterize the clofarabine disposition in mice for further preclinical efficacy studies, we evaluated the plasma and central nervous system disposition in a mouse model of ependymoma. A plasma pharmacokinetic study of clofarabine (45 mg/kg, IP) was performed in CD1 nude mice bearing ependymoma to obtain initial plasma pharmacokinetic parameters. These estimates were used to derive D-optimal plasma sampling time points for cerebral microdialysis studies. A simulation of clofarabine pharmacokinetics in mice and pediatric patients suggested that a dosage of 30 mg/kg IP in mice would give exposures comparable to that in children at a dosage of 148 mg/m(2). Cerebral microdialysis was performed to study the tumor extracellular fluid (ECF) disposition of clofarabine (30 mg/kg, IP) in the ependymoma cortical allografts. Plasma and tumor ECF concentration-time data were analyzed using a nonlinear mixed effects modeling approach. The median unbound fraction of clofarabine in mouse plasma was 0.79. The unbound tumor to plasma partition coefficient (K pt,uu: ratio of tumor to plasma AUCu,...Continue Reading

References

May 1, 1983·Journal of Neurochemistry·R HofsteinV E Shashoua
Dec 1, 1981·Journal of Pharmacokinetics and Biopharmaceutics·D Z D'Argenio
Nov 1, 1996·Computers in Biology and Medicine·E I Ette
Feb 13, 2001·Drug Discovery Today·W M. Pardridge
Apr 5, 2001·Journal of Pharmaceutical Sciences·I KarivK R Oldenburg
Mar 15, 2003·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·Hagop M KantarjianMichael Keating
Aug 6, 2004·Journal of Pharmaceutical Sciences·Markos LeggasClinton F Stewart
Mar 4, 2005·Drug Metabolism and Disposition : the Biological Fate of Chemicals·Peter L BonateJames Q Rose
Aug 24, 2005·Clinical Cancer Research : an Official Journal of the American Association for Cancer Research·Stacey L BergSusan M Blaney
Oct 4, 2006·Nature Reviews. Drug Discovery·Peter L BonateSteve Weitman
Aug 15, 2008·Neuro-oncology·Lee RidleyUNKNOWN Children's Cancer and Leukaemia Group Biological Studies Committee
Jul 7, 2009·Biochemical Pharmacology·Anna ZhenchukFreidoun Albertioni
Aug 5, 2009·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·Sima JehaPeter Steinherz
Feb 18, 2010·Computational Statistics & Data Analysis·Xiaoning WangDavid Z D'Argenio
May 13, 2010·Cancer Research·Angel M CarcabosoClinton F Stewart
Mar 31, 2012·Nature·C Glenn Begley, Lee M Ellis
Nov 26, 2013·European Journal of Pharmaceutical Sciences : Official Journal of the European Federation for Pharmaceutical Sciences·M O JacusC F Stewart
Mar 4, 2014·British Journal of Haematology·Anjali S AdvaniFrederick R Appelbaum

❮ Previous
Next ❯

Citations


❮ Previous
Next ❯

Related Concepts

Trending Feeds

COVID-19

Coronaviruses encompass a large family of viruses that cause the common cold as well as more serious diseases, such as the ongoing outbreak of coronavirus disease 2019 (COVID-19; formally known as 2019-nCoV). Coronaviruses can spread from animals to humans; symptoms include fever, cough, shortness of breath, and breathing difficulties; in more severe cases, infection can lead to death. This feed covers recent research on COVID-19.

Blastomycosis

Blastomycosis fungal infections spread through inhaling Blastomyces dermatitidis spores. Discover the latest research on blastomycosis fungal infections here.

Nuclear Pore Complex in ALS/FTD

Alterations in nucleocytoplasmic transport, controlled by the nuclear pore complex, may be involved in the pathomechanism underlying multiple neurodegenerative diseases including Amyotrophic Lateral Sclerosis and Frontotemporal Dementia. Here is the latest research on the nuclear pore complex in ALS and FTD.

Applications of Molecular Barcoding

The concept of molecular barcoding is that each original DNA or RNA molecule is attached to a unique sequence barcode. Sequence reads having different barcodes represent different original molecules, while sequence reads having the same barcode are results of PCR duplication from one original molecule. Discover the latest research on molecular barcoding here.

Chronic Fatigue Syndrome

Chronic fatigue syndrome is a disease characterized by unexplained disabling fatigue; the pathology of which is incompletely understood. Discover the latest research on chronic fatigue syndrome here.

Evolution of Pluripotency

Pluripotency refers to the ability of a cell to develop into three primary germ cell layers of the embryo. This feed focuses on the mechanisms that underlie the evolution of pluripotency. Here is the latest research.

Position Effect Variegation

Position Effect Variagation occurs when a gene is inactivated due to its positioning near heterochromatic regions within a chromosome. Discover the latest research on Position Effect Variagation here.

STING Receptor Agonists

Stimulator of IFN genes (STING) are a group of transmembrane proteins that are involved in the induction of type I interferon that is important in the innate immune response. The stimulation of STING has been an active area of research in the treatment of cancer and infectious diseases. Here is the latest research on STING receptor agonists.

Microbicide

Microbicides are products that can be applied to vaginal or rectal mucosal surfaces with the goal of preventing, or at least significantly reducing, the transmission of sexually transmitted infections. Here is the latest research on microbicides.

© 2022 Meta ULC. All rights reserved